A carregar...
A novel extracellular drug conjugate significantly inhibits head and neck squamous cell carcinoma
OBJECTIVES: Despite advances in treatment modalities, head and neck squamous cell carcinoma (HNSCC) remains a challenge to treat with poor survival and high morbidity, necessitating a therapy with greater efficacy. EDC22 is an extracellular drug conjugate of the monoclonal antibody targeting CD147 (...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3951319/ https://ncbi.nlm.nih.gov/pubmed/23920309 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.oraloncology.2013.07.006 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|